Literature DB >> 33692131

Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis.

Sang Woo Park1, Margarita Pons-Salort2, Kevin Messacar3,4, Camille Cook5, Lindsay Meyers5, Jeremy Farrar6, Bryan T Grenfell7,8,9.   

Abstract

Acute flaccid myelitis (AFM) recently emerged in the United States as a rare but serious neurological condition since 2012. Enterovirus D68 (EV-D68) is thought to be a main causative agent, but limited surveillance of EV-D68 in the United States has hampered the ability to assess their causal relationship. Using surveillance data from the BioFire Syndromic Trends epidemiology network in the United States from January 2014 to September 2019, we characterized the epidemiological dynamics of EV-D68 and found latitudinal gradient in the mean timing of EV-D68 cases, which are likely climate driven. We also demonstrated a strong spatiotemporal association of EV-D68 with AFM. Mathematical modeling suggested that the recent dominant biennial cycles of EV-D68 dynamics may not be stable. Nonetheless, we predicted that a major EV-D68 outbreak, and hence an AFM outbreak, would have still been possible in 2020 under normal epidemiological conditions. Nonpharmaceutical intervention efforts due to the ongoing COVID-19 pandemic are likely to have reduced the sizes of EV-D68 and AFM outbreaks in 2020, illustrating the broader epidemiological impact of the pandemic.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2021        PMID: 33692131     DOI: 10.1126/scitranslmed.abd2400

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  13 in total

1.  Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.

Authors:  Richard Janissen; Andrew Woodman; Djoshkun Shengjuler; Thomas Vallet; Kuo-Ming Lee; Louis Kuijpers; Ibrahim M Moustafa; Fiona Fitzgerald; Peng-Nien Huang; Angela L Perkins; Daniel A Harki; Jamie J Arnold; Belén Solano; Shin-Ru Shih; Marco Vignuzzi; Craig E Cameron; Nynke H Dekker
Journal:  Mol Cell       Date:  2021-10-22       Impact factor: 17.970

2.  Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.

Authors:  Kevin Messacar; Rachel E Baker; Sang Woo Park; Hai Nguyen-Tran; Jessica R Cataldi; Bryan Grenfell
Journal:  Lancet       Date:  2022-07-14       Impact factor: 202.731

3.  Evolution, geographic spreading, and demographic distribution of Enterovirus D68.

Authors:  Emma B Hodcroft; Robert Dyrdak; Cristina Andrés; Adrian Egli; Josiane Reist; Diego García Martínez de Artola; Julia Alcoba-Flórez; Hubert G M Niesters; Andrés Antón; Randy Poelman; Marijke Reynders; Elke Wollants; Richard A Neher; Jan Albert
Journal:  PLoS Pathog       Date:  2022-05-31       Impact factor: 7.464

4.  Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.

Authors:  Yanmei Hu; Naoya Kitamura; Rami Musharrafieh; Jun Wang
Journal:  J Med Chem       Date:  2021-06-04       Impact factor: 8.039

5.  The impact of long-term non-pharmaceutical interventions on COVID-19 epidemic dynamics and control: the value and limitations of early models.

Authors:  Marissa L Childs; Morgan P Kain; Mallory J Harris; Devin Kirk; Lisa Couper; Nicole Nova; Isabel Delwel; Jacob Ritchie; Alexander D Becker; Erin A Mordecai
Journal:  Proc Biol Sci       Date:  2021-08-25       Impact factor: 5.349

6.  Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens.

Authors:  Hai Nguyen-Tran; Sang Woo Park; Kevin Messacar; Samuel R Dominguez; Matthew R Vogt; Sallie Permar; Perdita Permaul; Michelle Hernandez; Daniel C Douek; Adrian B McDermott; C Jessica E Metcalf; Bryan Grenfell; Alicen B Spaulding
Journal:  Lancet Microbe       Date:  2022-01-07

7.  Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network, United States, July-November 2018-2020.

Authors:  Melisa M Shah; Ariana Perez; Joana Y Lively; Vasanthi Avadhanula; Julie A Boom; James Chappell; Janet A Englund; Wende Fregoe; Natasha B Halasa; Christopher J Harrison; Robert W Hickey; Eileen J Klein; Monica M McNeal; Marian G Michaels; Mary E Moffatt; Catherine Otten; Leila C Sahni; Elizabeth Schlaudecker; Jennifer E Schuster; Rangaraj Selvarangan; Mary A Staat; Laura S Stewart; Geoffrey A Weinberg; John V Williams; Terry Fan Fei Ng; Janell A Routh; Susan I Gerber; Meredith L McMorrow; Brian Rha; Claire M Midgley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-11-26       Impact factor: 17.586

8.  Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA.

Authors:  Robyn A Livingston; Christopher J Harrison; Rangaraj Selvarangan
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

Review 9.  Animal Models of Enterovirus D68 Infection and Disease.

Authors:  Meghan S Vermillion; Justin Dearing; Yun Zhang; Danielle R Adney; Richard H Scheuermann; Andrew Pekosz; E Bart Tarbet
Journal:  J Virol       Date:  2022-07-19       Impact factor: 6.549

10.  Detection of Enterovirus D68 in Wastewater Samples from the UK between July and November 2021.

Authors:  Alison Tedcastle; Thomas Wilton; Elaine Pegg; Dimitra Klapsa; Erika Bujaki; Ryan Mate; Martin Fritzsche; Manasi Majumdar; Javier Martin
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.